Cardinal Health CAH · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
274.29
+0.95%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Cardinal Health
From its filings with the US Securities and Exchange Commission
Cardinal Health is based in Dublin, Ohio and is incorporated in Ohio. Its shares trade on NYSE under the ticker CAH. It is a member of the S&P 500. The SEC classifies its business as wholesale-drugs, proprietaries & druggists' sundries. In the fiscal year to 30 June 2026, it reported revenue of $254.25bn and net income of $1.71bn. At that date it held total assets of $57.30bn and shareholders' equity of −$2.88bn.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 7 Sept 1994
- Employees
- 63,900
- Website
- cardinalhealth.com ↗
- Head office
- 7000 CARDINAL PLACE, DUBLIN, OH, 43017
- Incorporated in
- OH
- Classification
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Gregory KennyIndependent Non-Executive Chairman of the Board$570,011
- Mr. Jason HollarChief Executive Officer, Director, since 2020$19.0m
- Mr. Aaron AltChief Financial Officer$6.2m
- Mr. Stephen MasonCorporate Executive - GMPD segment$4.7m
- Ms. Deborah WeitzmanChief Executive Officer of Pharmaceutical and Specialty Solutions Segment$5.5m
- Ms. Ola SnowChief Human Resources Officer
- Ms. Michelle GreeneExecutive Vice President, Chief Information Officer, Customer Support Services
- Ms. Jessica MayerChief Legal and Compliance Officer$4.9m
- Mr. Robert AzelbyIndependent Director$321,953
- Ms. Michelle BrennanIndependent Director$319,953
- Ms. Sheri EdisonIndependent Director$339,953
- Mr. David EvansIndependent Director, since 2019$321,953
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 90
- Environment
- 93
- Social
- 85
- Governance
- 92
- Direct emissions (scope 1)
- 160,150 t
- Energy emissions (scope 2)
- 205,710 t
- Value chain emissions (scope 3)
- 22,437,666 t
- Women in the workforce
- 51.1%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Extensive distribution network facilitating efficient supply chain management.
- Diversified product portfolio including pharmaceuticals, medical and surgical products.
- Strong brand reputation and recognition in the healthcare industry.
- Well-established relationships with various healthcare providers.
- Ability to leverage technology to enhance operational efficiency.
Weaknesses
- Dependence on a limited number of large customers for a significant portion of revenue.
- Vulnerability to changes in government regulations and reimbursement policies.
- Reliance on external suppliers for raw materials and finished products.
- High competition within the healthcare distribution industry.
- Occasional product recalls impacting customer trust.
Opportunities
- Growing demand for healthcare services due to aging population and increasing chronic diseases.
- Expansion into emerging markets with evolving healthcare systems.
- Strategic partnerships and acquisitions to enhance market presence and diversify offerings.
- Adoption of advanced technologies and data analytics for improved efficiency and patient care.
- Increasing focus on personalized medicine and home healthcare.
Threats
- Intense competition from other healthcare distributors and manufacturers.
- Cost containment measures in the healthcare industry impacting profit margins.
- Economic downturns affecting customer spending on healthcare products.
- Legal and regulatory risks associated with the healthcare industry.
- Potential disruptions in the global supply chain due to geopolitical events or natural disasters.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.